General MedicationsINJECTIONStandard
IODIXANOL
IODIXANOL
Standard Dose
55%
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary
Approval overview IODIXANOL is listed in Drugs@FDA under application 214271 (ANDA).
Review priority: UNKNOWN Marketing status: Prescription Active ingredient IODIXANOL Form and strength INJECTABLE;INJECTION - 55% Sponsor HENGRUI PHARMA Submission history Latest submission status date: 2025-06-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview IODIXANOL is listed in Drugs@FDA under application 214271 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient IODIXANOL Form and strength INJECTABLE;INJECTION - 55% Sponsor HENGRUI PHARMA Submission history Latest submission status date: 2025-06-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.